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Cu(II) complexes of a tridentate N,N,O-donor Schiff base 
of pyridoxal: Synthesis, X-ray structures, DNA-binding 
properties and catecholase activity 
Satyajit Mondal,a Moumita Chakraborty,a Antu Mondal,a Bholanath Pakhira,a Alexander J. Blake,b  
Ekkehard Sinn,c Shyamal Kumar Chattopadhyay*a 
Two new Cu(II) complexes [Cu(L1)(N3)](1) and [Cu(L1)(NCS)]n(2), where HL1 ((E)-4-((2(dimethylamino)ethylimino)methyl)-5-(hydroxymethyl)-2-
methylpyridin-3-ol) is a N,N,O-donor Schiff base ligand, have been synthesized. These complexes were characterized on the basis of 
spectroscopic, electrochemical, and other physicochemical properties. X-ray crystal structure determination reveals that in complex 1, Cu(II) 
is in a square planar geometry with the N,N,O-donor ligand and a terminally coordinated azide ion. In complex 2, however, Cu(II) assumes a 
square pyramidal geometry, and apart from the tridentate Schiff base ligand there is a thiocyanate ion, which acts in a µ1,3-bridging mode, 
connecting adjacent Cu(II) atoms in an axial-equatorial fashion forming an one dimensional chain. Cyclic voltammetry shows that complexes 
undergo Cu(II)/Cu(I) reductions at −0.40 to −0.55V followed by imine reduction at around −0.7V. Cu(I)/Cu(0) reduction is observed at 
approximately −0.9V. Complex 1 also shows appreciable catalytic activity for the aerial oxidation of 3,5 DTBCH2 to DTBQ (catecholase activity). 
Both the complexes also show strong binding affinity towards calf-thymus DNA. 
1. Introduction 
Cu(II) ion plays an important role in biological systems and it is at the active 
site of various enzymes such as catechol oxidase, superoxide dismutase, 
multicopper oxidases.1-8 Catechol oxidase is a copper-containing enzyme 
whose activity is similar to that of tyrosinase, a related class of copper 
oxidases. They are ubiquitous plant enzymes that catalyze oxidation of a 
broad range of ortho-diphenols to the corresponding o-quinones coupled 
with the reduction of oxygen to water. Krebs and co-workers reported the 
crystal structures of deoxy and met forms of catechol oxidase which reveal 
that these proteins have a dinuclear copper center.1,9 The crystal structures 
of catechol oxidase have enhanced the understanding of the mechanism of 
catecholase activity of tyrosinase and/or catechol oxidase. Mechanisms of 
catechol oxidation by the neutral enzyme or synthetic model complexes 
have been proposed by various workers, prominent among them are the 
catalytic cycles proposed by Solomon, and Krebs.1,4,10,11 Model complexes 
have played an important role in understanding the structural, 
spectroscopic and catalytic properties of the copper sites in protiens.12-26 
Various workers have tried to rationalize the catalytic efficiency of the 
catechol oxidation reaction with variety of parameters like redox 
potentials, solvent effect, pH of the medium, number and nature of 
bridging ligands, effect of secondary coordination sphere etc., however our 
knowledge in this direction is still sketchy and incomplete.12,13,17-26 
Therefore, there is need for study of new model complexes showing 
catecholase activity and exploration of relationship between their 
structural, spectroscopic and catalytic properties.  
From biological point of view, study of the Schiff bases of pyridoxal and 
their metal complexes are attractive for multiple reasons: pyridoxal is a 
close analogue of pyridoxine (vitamin B6) and thus its complexes may be 
bio-tolerable,27 the manganese(II) complex of dipyridoxal diphosphate 
(N,N′-dipyridoxylethylenediamine-N,N′-diaceticacid 5,5′-bis(phosphate)) is a 
contrast agent for magnetic resonance imaging of the liver,28,29 Cu(II) 
complex of pyridoxal has proven to be a highly promising candidate for the 
treatment of diabetic complications,30 and so on. Therefore, we though it 
will be meaningful to synthesize pyridoxal appended ligands and to explore 
catalytic and biological properties of metal complexes of such ligands.26,31  
Pseudohalide ions such as (N3−, NCS−, NCO−, and N(NC)2−) are versatile 
ligands that can bind transition metal ions in different of ways. They can 
behave as monodentate or as bridging ligands leading to the formation of 
mononuclear and polynuclear species. Among these, the azide and 
thiocyanate containing metal complexes are the most investigated systems 
because of their diverse structures and applications in magnetic 
materials.32-34 The azide anion can bind to the metal ion through end on 
(EO) bridging mode, generally leading to ferromagnetic coupling, while the 
end to end (EE) bridging results in antiferromagnetic coupling. 
Furthermore, EE and EO bridging modes may simultaneously exist in some 
species, leading to different topologies and materials with unprecedented, 
magnetic behaviour.35-37 On the other hand SCN− anion is a highly versatile 
ambidentate ligand with two donor atoms. It can coordinate either through 
the N or the S atom, or both, giving rise to linkage isomers,38,39 dimers40 or 
polymers.41 
The interaction of small molecules with DNA has been an active area of 
research at the interface of chemistry and biology.42-47 These small 
molecules are stabilized on binding to DNA through a series of weak 
interactions, such as the π-stacking interactions associated with 
intercalation of a planar aromatic group between the base pairs, hydrogen-
bonding and van der Waals interactions of functionalities bound along the 
groove of the DNA helix,48 and the electrostatic interaction of the cation 
with phosphate group of DNA.49 In recent years there is significant upsurge 
in the study of binding of transition metal complexes to DNA, with the aim 
of developing new DNA foot printing and DNA cleaving agents as well as 
identifying potential anticancer drugs.50-54    
In this paper, we describe, the syntheses of two Cu(II) complexes 
[Cu(L1)(N3)](1) and [Cu(L1)(NCS)]n (2), of  a N,N,O-donor pyridoxal Schiff 
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base ligand (HL1). Their single crystal X-ray structures have been 
determined. The spectroscopic and electrochemical properties of the 
complexes were investigated. DNA binding affinity of these complexes was 
also studied. 3,5-DTBC was used as a model substrate to study the 
catecholase activity of the complexes and only 1 was found to be 
catalytically active. 
2. Experimental 
2.1 Materials and methods  
Pyridoxal hydrochloride was purchased from Aldrich and 
triethylenetetramine was purchased from E. Merck. All other chemicals and 
solvents were of reagent grade and used as such. Solvents for spectroscopic 
and cyclic voltammetry studies were of HPLC grade obtained from Merck 
or Aldrich. Elemental analyses were performed on a Perkin–Elmer 2400 C, 
H, N analyzer. Infrared spectra were recorded as KBr pellets on a JASCO FT-
IR-460 spectrophotometer. UV–Vis spectra were recorded using a JASCO V-
630 spectrophotometer. 1H NMR spectra were recorded on a Bruker 
AVANCE DPX 300 MHz spectrometer using, Si(CH3)4 as internal standard. 
ESI-MS spectra of the samples were recorded on JEOL JMS 600 instrument. 
Fluorescence spectra at room temperature were recorded using PTI made 
QuantaMaster40 spectro-fluoremeter. EPR spectrum of complex 2 was 
recorded in DMF solution at 77K with a Varian E-112 EPR Spectrometer at 
SAIF, IIT, Bombay. 
 
2.2 Synthesis of Ligand (HL1) 
 Pyridoxal hydrochloride (0.203 g, 1mmol) was dissolved in 40 mL methanol 
and the pH was set to 6.5-7.0 by addition of concentrated aqueous KOH 
solution. On dropwise addition of methanolic N,N-
dimethylethylenediamine (0.088 g, 1mmol) to the neutral pyridoxal 
solution, the reaction mixture turned light yellow with no formation of 
precipitate. The solution was refluxed for three hours and then the solvent 
was evaporated on a rotary evaporator, when a yellowish brown oily 
product was obtained. It was triturated with acetone and then 
recrystallized from methanol to give a yellow hygroscopic solid. The ligand 
was characterized by analytical, spectral (IR, NMR, UV-vis, Emission, ESI-
MS) and electrochemical studies. Yield: 205 mg (86%). Anal.calc.for 
C12H19N3O2 (MW 237.15): C, 60.74; H, 8.07; N, 17.71. Found: C, 60.44; H, 
8.26; N, 17.91%.  ESI-MS: m/z: 238.04 [(L +H])+ (100) % (Figure S1 in the 
Supporting Information, SI). 1H-NMR (DMSO-d6): δ(ppm): 8.75(1H, s), 
7.8(1H, s), 4.5 (2H, s), 2.8(2H, d), 2.7-2.6(2H, t), 2.5(3H, s), 2.1(3H, s), 
1.94(3H, s) (Figure S2 in the SI). 13C-NMR(DMSO-d6): δ(ppm): 134.88, 
133.31, 132.1, 129.13, 70.60, 67.85, 59.09, 30.23, 28.80, 22.85, 14.36, 
11.260 (Figure S3 in the SI). Electronic spectrum in (0.01 M Tris-HCl buffer, 
pH 7.4):  λmax/nm(εmax /M−1cm−1): 416 (sh, 1640), 333(8321), 287(9272), 
250(12290). Selected IR bands (cm−1): 3406 br(νO-H), 3042 (νN-H), 1628 (νC=N) 
(Figure S4 in the SI). 
 
2.3. Synthesis of the complexes 
A methanolic solution (5 ml) of the ligand HL1 (0.206 g, 1 mmol) was added 
dropwise to a solution of Cu(ClO4)2∙6H2O (0.370 g, 1 mmol) in the same 
solvent (5 ml). After the mixture was refluxed for 1 h, an aqueous solution 
of NaN3 (0.130 g, 2 mmol) or KSCN (0.194 g, 2 mmol) was added, and the 
resulting mixture was refluxed for further 3 h. The green solution was 
filtered and the supernatant liquid was kept at room temperature for slow 
evaporation. After one day, green crystals of [Cu(L1)(N3)] (1) or 
[Cu(L1)(SCN)]n (2), suitable for X-ray structure determination were 
obtained. 
 
For [Cu(L1)(N3)](1) 
Yield: 270 mg (79%). Anal. calc. for C12H18CuN6O2 (M.W. 341∙86):C, 42.12; 
H, 5.26; N, 24.6. Found: C, 42.26; H, 5.30; N, 24.4%. MS: m/z: 299.09 
[CuL1]+(100%)] (Figure S5 in SI). Electronic spectrum in CH3OH solution 
λmax/nm(εmax/M−1cm−1): 613(163), 384(3970) 270(7108), 228(13467). 
Selected IR bands (cm−1): 3398br(νOH), 2930(νCH), 2057(νN3), 1641(νC=N), 
1422(νC–O phenol). 
For [Cu(L1)(NCS)]n(2) 
Yield: 290 mg (80%). Anal. calc. for C12H18CuN4O3S (M.W. 359.91): C, 39.8; 
H, 4.97; N, 15.5. Found: C, 39.35; H, 4.85; N, 15.34%. MS: m/z: 301.15 
[CuL1H]+(100%)] (Figure S6 in SI). Electronic spectrum in CH3OH solution 
λmax/nm(εmax/M−1cm−1): 634(142), 388(3902), 270(7416), 223(14448). 
Selected IR bands (cm−1): 3232br(νOH), 2095(νSCN), 1628(νC=N), 1417(νC–O 
phenol).  
Table 1:  Crystal data and refinement details of 1 and 2. 
 
2.4 X-ray crystallography 
 
X-ray diffraction data for 1 was collected on a Agilent GV1000 Atlas 
diffractometer at 150(2)K using Cu-Kα radiation (λ= 1.54184 Å).  Data 
collection and reduction were done using CrysalisPro program55 and 
empirical absorption correction using spherical harmonics, were 
implemented in Scale3 Abspack Scaling Algorithm within CrysalisPro. 
Structure was solved by Direct method using SHELXS 97 and refined by full-
matrix least-squares on F2 using SHELEXL version 2014/3.56,57 X-ray 
diffraction data for 2 was collected on a Bruker SMART APEX II 
diffractometer at 100 (2) K, utilizing a graphite monochromated Mo-Kα 
radiation (λ= 0.71073 Å). Data was indexed and refined as a nonmerohedral 
twin with two domains using Bruker SAINT V8.18C program.58 The ratio 
between the domains is 0.190(5). Structure was solved by Direct method 
using SHELXS-97 and refined by full-matrix least-squares on F2 using 
SHELEXL version 2017/1.56,57 Data were corrected for absorption effects 
using the Bruker ‘TWINABS’ program.59 The non-hydrogen atoms were 
refined with anisotropic displacement parameters. All hydrogen atoms 
were placed at calculated positions and refined as riding atoms using 
Compounds 1 2 
Formula C12H18CuN6O2 C12H18CuN4O3S 
Formula weight 341.86 359.91 
Crystal size(mm) 0.393×0.194×0.151 0.20×0.18×0.105 
Temperature (K) 150(2) 100(2) 
Crystal system Monoclinic Monoclinic 
Space group P 21/c P 21/n 
a (Å) 6.7493(17) 11.2788(4) 
b (Å) 11.511(3) 10.1456(4) 
c(Å) 17.901(5) 14.1768(5) 
α(°) 90 90 
β(°) 94.172(11) 112.976(2) 
γ(°) 90 90 
dcal 1.637 1.592 
µ(mm−1) 1.590 1.611 
F(000) 708 740 
Total Reflections 3398 3564 
Observed data [ I>2σ(I)] 2407 2594 
R1, wR2 [I>2σ(I)] 0.0573, 0.0997 0.0479, 0.0997 
R1, wR2 (all data) 0.0991, 0.1269 0.0851, 0.1151 
Data/restraints/parameters 3398/0/206 3564/0/197 
Goodness-of-fit (GOF) on F2 1.053 1.057 
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isotropic displacement parameters. A summary of the crystallographic data 
is presented in Table 1. Important bond distances and bond angles are 
collected in Table 2. Crystal data have been deposited at CCDC with 
deposition numbers 1817674 and 1817791 for and 1 and 2 respectively. 
 
2.5. DNA-binding experiments  
2.5.1. Absorption spectral studies 
 
The DNA binding experiments were performed in Tris–HCl/NaCl buffer (50 
mM Tris–HCl/1 mM NaCl buffer, pH 7.3) using a methanol (CH3OH) solution 
of complexes 1 and 2. The concentration of CT-DNA was determined from 
the absorption intensity at 260 nm with a ε value of 6600 M−1cm−1.60 The 
UV absorbance ratio at 260 and 280 nm (A260/A280) of 1.85 indicated that 
the DNA was sufficiently free of protein contamination.61 The DNA stock 
solution was stored at 4°C in the dark and used within 4 days after 
preparation. The concentrated stock solutions of complexes 1 and 2 were 
prepared by dissolving them in CH3OH and diluting suitably with Tris–HCl 
(pH 7.4) buffer. Complex-DNA solutions were allowed to incubate for 5 min 
before the absorption spectra were recorded. The intrinsic binding 
constant Kb was calculated from the spectroscopic titration data using the 
following equation:62 
 
[DNA]/(εa − εf) = [DNA]/(εb − εf) + 1/Kb(εb − εf) ....................(1) 
 
where εf and εb are the extinction coefficients of the free and fully bound 
complex while εa is the extinction coefficient observed for the absorption 
band at a given DNA concentration, Kb the equilibrium binding constant. A 
plot of [DNA]/(εa − εf) versus [DNA] gives Kb as the ratio of the slope to the 
intercept. 
 
2.5.2. Fluorescence spectral studies 
For fluorescence quenching experiments DNA was pretreated with 
ethidium bromide and kept in at 4°C for 4 hour. The complexes were then 
added to this mixture and their effect on the emission intensity was 
measured using PTI made QuantaMaster40 spectro-fluoremeter. Samples 
were excited at 520 nm and emission was observed between 540 to 700 
nm. 
 
2.6. Electrochemical studies 
Electrochemical data of 1-2 mM DMF solutions of the complexes were 
collected using a CH1106A potentiostat. A three electrode configuration, 
consisting of a glassy carbon working electrode and a Pt-wire auxiliary 
electrode, TEAP as supporting electrolyte and Ag,AgCl/KCl reference 
electrode, with scan rate rate (20-100) Vs−1 was used. The potentials were 
calibrated against the ferrocene/ferrocenium couple (E0 = 0.44 V). 
Electrochemical titrations of copper complexes with CT-DNA were 
recorded by cyclic voltammetry and DPV in DMF solutions at room 
temperature. 
2.7 Catalytic activity for the oxidation of 3,5-di-tert-butylcatechol 
The catalytic oxidation of substrate 3,5-di-tert-butylcatechol (DTBCH2) by 
[Cu(L)(N3)] (1) complex was performed in methanol at room temperature. 
The reaction was carried out spectrophotometrically by monitoring the 
increase in the absorbance band of 3,5-di-tert-butyl-1,2-benzoquinone 
(3,5-DTBQ) at 400 nm as a function of time. Absorbance vs. wavelength 
plots were recorded for these solutions at a regular time interval of 5 min 
in the range 300–500 nm. The minimum and maximum complex to 
substrate ratio was 1:16 and 1:500 respectively. Km, Vmax and kcat values 
were determined by Lineweaver–Burk plots and Michaelis–Menten 
equation. 
2.8 Detection of Hydrogen Peroxide in the Catalytic Reaction 
The presence of hydrogen peroxide in the reaction mixture was analyzed 
iodometrically by assaying I3–, which has a characteristic absorption band 
at 353 nm (ε = 26000 M–1cm–1 in water). The oxidation reaction of DTBCH2 
by complex 1 was carried out as described in the kinetic experiment. When 
the formation of quinone reached a desired value at 400 nm the solution 
was acidified with H2SO4 to pH 2 to stop the reaction. Water (3 ml) was 
added and the reaction mixture was then extracted two times with CH2Cl2 
to remove the DTBQ formed during the reaction. To a 2 ml aliquot of the 
aqueous layer 1 ml of a KI solution (0.3 M) was added with a catalytic 
amount of ammonium molybdate (3% solution) to accelerate the 
formation of I3–. Blank experiments were performed under identical 
conditions in the presence of DTBQ and complex 1, but only minor 
formation of I3–was observed. 
2.9 DFT 
In order to understand the electronic structure of the synthesized 
complex 1 and 2, we have carried out DFT calculations with the Gaussian 
03 package (revision B.04).63 Molecular orbitals were visualized using Gauss 
View. Single point calculations, and population analysis of the molecular 
orbitals were carried out using the density functional theory (DFT) with 
B3LYP hybrid exchange functional.64,65 For H, C, N and O atoms 6-31G* basis 
set were used.66 The LANL2DZ basis set67 and LANL2DZ pseudopotentials of 
Hay and Wadt68 were used for the Cu atom. The geometry of the complexes 
was taken from the crystal structure, and single point energy calculated, 
without further optimization, in gas phase.  
 
3. Results and discussion 
3.1 Synthesis of complexes 
The Cu(II) complexes 1 and 2 were synthesized by refluxing a mixture of 
methanolic solution of Cu(ClO4)2∙6H2O and aqueous solution of pseudo 
halides (NaN3, KSCN) with the ligand. After filtration, on slow evaporation 
of the filtrate at room temperature, green colored square shaped crystals 
of the complexes suitable for X-ray diffraction studies, appeared after 1 
day. A simple scheme showing the synthesis of complex is depicted in 
Scheme I. The isolated complexes were characterized by elemental 
analysis, IR, UV–vis spectroscopy, CV, and by single-crystal X-ray 
crystallography. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme I:  Schematic representation of the synthesis of the Metal complexes. 
 
3.2 Description of X-ray crystal structure 
The ORTEP diagrams along with atom numbering scheme for complexes 1 
and 2 are shown in Figures 1 and 2 respectively and the important bond 
lengths and angles are listed in Table 2. In the complex 1, the copper ion 
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occupies the central position of a regular square planar arrangement. Out 
of its four coordination sites three are occupied by the phenolato oxygen, 
imine nitrogen, and the tertiary amine nitrogen of the tridentate ligand. 
The remaining fourth coordination site is satisfied by an azido group which 
is linked to Cu(II) ion through a terminal nitrogen atom. The azide group, 
which acts as a monodentate ligand is slightly asymmetric [N(4)–
N(5)=1.184(2) and N(5)–N(6)=1.163(2)Å] and linear within the 
experimental error [N(6)–N(5)–N(4)=177.1(2)°]. The structure of 1, 
however, differs from few other X-ray crystallographically investigated 
Cu(II) azide complexes containing terminal azido ligand.69,70 In most of the 
Cu(II) complexes having a terminal azide ligand the coordination geometry 
around copper ion is either pseudo octahedral or distorted trigonal 
bipyramidal, while square planar arrangement, as observed in complex 1, 
is not so common. 
In complex 2, however, Cu(II) assumes a square pyramidal geometry (τ = 
0.18; τ = 0 for square pyramid and 1 for trigonal bipyramid). The N,N,O-
donor atoms of the tridentate ligand along with a thiocyanate N occupies 
the square plane, and the axial position is occupied by a thiocyanate sulfur 
atom of an adjacent unit at ½ ‒ x, ½ + y, ½ ‒ z. The thiocyanate ion thus acts 
as a µ1,3‒bridge connecting adjacent Cu(II) atoms in an axial– equatorial 
fashion, forming an one-dimensional chain along ‘b’ axis (Figure S 7). 
 
 
 
 
 
 
 
 
 
 
 
 
                       Figure 1 ORTEP diagram (50% probability level) for 1. 
 
 
 
 
 
 
 
 
 
 
 
               Figure 2 ORTEP diagram (50% probability level) for 2. 
 
Table 2 Selected bond distances (Å) & bond angles (0) for 1 and 2. 
1 
Bond lengths [Å] Bond angles [°] 
Cu1‒N1 1.9313(16) N1‒Cu1‒N2 84.72(7) 
Cu1‒N2 2.0627(16) N1‒Cu1‒N4 169.23(7) 
Cu1‒N4 1.9591(17) N2‒Cu1‒N4 90.17(7) 
Cu1‒O1 1.9088(13) O1‒Cu1‒N1 93.07(6) 
  O1‒Cu1‒N2 173.78(6) 
  O1‒Cu1‒N4 92.94(7) 
2 
Cu1‒ N1 1.949(3) N1‒ Cu1‒ N2 84.23(12) 
Cu1‒ N2 2.045(3) N1‒ Cu1‒ N4 164.54(13) 
Cu1‒ N4 1.972(3) N2‒ Cu1‒ N4 92.06(12) 
Cu1‒ O1 1.900(3) O1‒ Cu1‒ N1 92.84(11) 
Cu1‒ S1b 2.836(1) O1‒ Cu1‒ N2 175.33(10) 
  O1‒ Cu1‒ N4 89.82(11) 
Symmetry code b = ½ ‒ x, ½ + y, ½ − z 
3.3 Infrared spectra 
In the complexes bands appearing at 3402 and 3228 cm−1 are assigned to 
the O‒H stretching vibrations of coordinated hydroxymethyl group and 
bands at 2928 and 2920 cm−1 indicate the presence of aromatic C−H 
stretching vibration of pyridine moiety. The band corresponding to the C=N 
stretching vibration appears at 1629 cm−1 in the ligand, which shifts to 
higher wavelength at 1644 cm−1 in the complexes indicating imine nitrogen 
is coordinated to metal atom. Complex 1 shows strong sharp absorption 
band at 2062 cm−1 corresponds to the asymmetric stretching mode of 
monodentate azide ligand (Figure S8). Free azide ion in NaN3 shows single 
strong absorption centred at 2133 cm−1.71 The shift to lower wave numbers 
indicates the coordination of azide ion to Cu(II) in the complex. Potassium 
thiocyanate shows a very strong band at 2048 cm−1 in i.r spectrum, which 
is caused by the CN stretching vibration. However, in complex 2 this band 
is shifted to higher frequency at ∼2100 cm−1 suggesting coordination of the 
thiocyanate group to the metal centre (Figure S8). 
 
3.4 Electronic spectra 
The absorption spectra of the ligand (HL1), and the complexes 1 and 2, were 
recorded at a concentration of 10−4 M in CH3OH, as the complexes show 
good solubility in CH3OH. The spectrum of the ligand exhibits two 
absorption bands at 287 and 333 nm attributable to the π→ π* transition 
associated with the azomethine chromophore and n→π* transitions 
involving the phenolic oxygen respectively. In the case of the complexes 1 
and 2, the n→π* transition was shifted to a much greater extent, from 333 
to 384 or 388 nm; this indicates the phenolic oxygen had lost a hydrogen 
on coordination to the metal centre. The broad transition around 615 and 
634 nm for complexes 1 and 2 respectively corresponds to a d-d transition 
of the Cu(II) centre (Figure 3).72 
 
 
                          (a)                                            
(b) 
 
 
                          (c)                                                      
(d) 
 
             Figure 3 Electronic spectra 
of the complexes 1 (a and b) and 2 
(c and d).  
3.5 Cyclic voltammetry studies: 
In cyclic voltammetry (CV) 
experiments, on the negative side of the reference electrode, complex 1 shows 
two overlapping reductive peaks at −0.66 V and −0.87 V. On scan reversal a broad 
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anodic wave spanning −0.4 to −0.6 V was observed (Figure 4). In the differential 
pulse voltammetry (DPV) two well resolved peaks at −0.55 V and −0.68 V were 
observed. The tail of the second reductive wave extends beyond −1.0 V, but no 
peak could be resolved between −0.8 to −1.0 V. We believe the CV peak at −0.66 
V corresponds to DPV peaks at −0.55 V and −0.68 V and they denote Cu(II)/Cu(I) 
and imine reductions respectively (note that β-LUMO is predominantly metal 
centered while α-LUMO has appreciable contribution from imine part of the 
ligand, vide infra). The Zn(II) complex of the ligand shows a reductive DPV peaks 
at −0.66 V and this supports the above assignment (Figure S9). The CV peak at 
−0.87 V probably corresponds to Cu(I)/Cu(0) reduction, which is buried under the 
tail of the ligand reduction peak in DPV.  
In the case of complex 2 in CV, a quasi-reversible reductive wave at −0.42 V (ΔEp 
= 190 mV) is followed by a near irreversible reductive peak at −0.87 V. In DPV, 
again three well resolved peaks are observed at −0.43, −0.61 and −0.78 V. 
However, the last two peaks have current heights much smaller than the peak at 
−0.43 V. Following the discussion for complex 1, we assigned the three peaks at 
−0.43, −0.61 and −0.78 V to Cu(II)/Cu(I), imine reduction and Cu(I)/Cu(0) 
processes respectively. Probably on reduction to Cu(I) the complex undergoes 
ligand dissociation in this case and this may explain the relatively smaller peak 
heights of the peaks at −0.61 and −0.78 V.  
CV and DPV provide an additional and sensitive tool to study binding of 
metal complexes to DNA. On addition of DNA to complex 1, the DPV peaks shift 
towards less negative value. The difference in redox potential between the DNA- 
bound complex and the free complex is represented by following equation: Eb-Ef 
= 0.059 log(Kred/Kox), where Kred and Kox are, respectively, stability constants of the 
binding of the oxidized (Kox) or reduced forms (Kred) with DNA and Eb and Ef are 
redox potentials in bound and free forms of the complex. The positive value of 
Eb-Ef  (0.06V) for complex 1 indicates that the reduced complex binds to the DNA 
approximately ten times stronger than the oxidized form. 
 
Figure 4 CV and DPV of complex 1 and 2 in DMF solution upon addition of DNA (DNA 
1 and DNA2 refers to increasing amount of DNA), at a GC electrode at 100 mV s−1 
scan rate. 
Unlike complex 1, addition of DNA to complex 2 does not change the peak 
positions of DPV much, indicating the oxidized and reduced complexes have very 
similar affinity for DNA.  
 
3.6 EPR spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 X-band EPR spectrum of complex 2 in DMF glass at 77K. 
EPR spectra is an important tool to study the electronic and geometrical 
features of Cu(II) complexes. We have recorded the epr spectrum of 
complex 2, as a representative example, in DMF solution at 77K (Figure 5). 
The complex shows typical axial spectra expected of a 4+1 coordinated 
complex with g (2.23) > g⊥ (2.05), and A = 168 × 10−4 cm−1, indicating the 
unpaired electron is in dx2-y2 orbital.  
3.7 DNA binding study  
3.7.1 Absorption spectroscopic studies 
The interaction of variety of small molecules (metal complexes) with DNA double 
helix occurs by three distinct binding modes. They are, (i) Electrostatic binding / 
External binding: Complexes are positively charged and the DNA phosphate sugar 
backbone is negatively charged and their interaction is known as electrostatic. (ii) 
Groove binding: The molecules approach within van der Waals contact and reside 
in the DNA groove. Hydrophobic and/or hydrogen- 
         
                      
                               
                              
 
 
 
 
 
 
                                       (a)                                                        (b) 
                           
 
 
 
 
 
 
 
 
                             (c)                                                      (d) 
Figure 6 Absorption spectra of complexes 1 (a) and 2 (c) (1.0 × 10−4, 5.0 × 10−5 M 
respectively) in the presence of increasing amounts of CT-DNA (3.0 × 10−4, 1.0 × 10−4 
M) at room temperature in 5 mM Tris-HCl/NaCl buffer (pH = 7.4) at 25°C. The arrow 
shows the absorbance changing upon increasing the DNA concentration. The plots of 
[DNA]/εa – εf) versus [DNA] for the titration of DNA with the Cu(II) complexes are 
shown in (b) and (d). 
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bonding are usually important components of this binding process, and provide 
stabilization. (iii) Intercalative binding / Intercalation: this association involves the 
insertion of planar fused aromatic ring system between the DNA base pairs,  
leading to significant π- electron overlap. The study of the binding capacity of the 
metal complexes to DNA double helix may be studied by electronic absorption 
spectroscopy, which follows the changes in the absorbance and shift in 
wavelength (Figure 6). The variation of absorption spectra with the addition of 
CT-DNA to the solution of the complexes was followed. It was seen that on 
binding of DNA by the complexes, the UV absorbance at 270 nm increases, this 
absorbance increase is referred to as a "hyperchromic shift" or the hyperchromic 
effect. The characteristic feature of hyperchromic shift is the extent of increase 
of the absorbance of the ligand centered band.73 With increase of concentration 
of CT- DNA, both the complexes showed a hyperchromic and a slight blue-shifted 
LC band in the absorption spectra. The hyperchromic values observed in the 
presence of DNA were in the range 17.4–57.2%, and their blue shifts are by 3-4 
nm (Table 3). The intrinsic binding constant Kb calculated from the plots of 
[DNA]/(εa- εf) verses [DNA] can be obtained from the ratio of the slope to the 
intercept. Using the hyperchromism at 266 and 270 nm the intrinsic binding 
constant Kb for DNA binding by the complexes 1 and 2 were determined to be 5.4 
× 108 and 1.08 × 105 M−1 respectively. The exceptionally high value of Kb for 1, 
which is relatively higher than the classical intercalator (ethidium bromide; 1.4 × 
106 M−1), suggests the complex is an avid binder of DNA. Since such high binding 
constant is generally characteristic of DNA binding by intercalation, so we assume 
that the complexes 1 and 2 bind DNA predominantly by intercalation, though H-
bonding, electrostatic interactions as well as interactions with the phosphate 
groups of DNA may also lend their contribution towards overall binding strength. 
 
 
Table 3: Electronic absorption spectral properties of the complexes on DNA binding.  
 
 
aH% = [(Abound - Afree) /Abound] × 100%; bKb = Intrinsic DNA binding constant determined 
from the UV - Vis absorption spectral titration, cKSV and cKapp are Stern-Volmer 
constant and apparent binding constant obtained from fluorescence spectrsocopy 
3.7.2 Fluorescence binding study 
Ethidium bromide is a planar cationic dye which is widely used as a sensitive 
fluorescence probe for native DNA. Its fluorescence intensity is very weak, 
but it is greatly increased when EB is specifically intercalated into the base 
pairs of DNA.74,75 Furthermore, this fluorescence is quenched by the 
addition of another molecule that displaces EB from DNA.54 It was found 
that the fluorescence intensity of CT-DNA-EB decreased remarkably with 
the addition of the complexes 1 and 2 (Figure 7), which indicated that the 
complexes can bind DNA and replace EB from the CT-DNA-EB system.76 The 
fluorescence quenching data can be fitted with Stern Volmer equation:77 
I0/I = 1 +Ksv[Q], where Ksv is the quenching constant, and [Q] is the 
quencher concentration. In the linear fit plot of I0/I versus [complex], Ksv is 
given by the slope of the plot. The Ksv values for the complexes 1 and 2 
were determined to be 1.67 × 105M−1 (R2 = 0.990) and 2.12 × 105M−1 (R = 
0.990) (I0 is the emission intensity of EB-DNA in the absence of complex; I 
is the emission intensity of EB-DNA in the presence of complex). The 
apparent binding constant (Kapp) was estimated at 1.07 × 107 M−1 for 1 and 
2.46 × 106 M−1 for 2 (Table 3) using the equation KEB[EB] = Kapp[complex], 
where the complex concentration was the value at a 50% reduction of 
fluorescence intensity of EB and KEB is 1.0 × 107 M−1 and [EB] was taken as 
5.0 × 10−6 M−1.78 The high Kapp value implies that the complexes 1 and 2 
can strongly interact with DNA.  
 
 
 
 
 
        
             (a)                                                              (b) 
 
 
 
 
 
                             (c)                                                              (d)  
Figure 7 Fluorescence titration of Ethidium bromide-DNA complex with complex 1 (a) 
and 2(c) and their Stern Volmer plots (b for complex 1 and d for complex 2) 
3.8 Catecholase activity of Complex 1 
3.8.1 Kinetics of 3, 5-di-tert-butylcatechol oxidation 
Kinetic experiments for the oxidation of DTBCH2 (3,5-di-tertbutylcatechol) 
by [Cu(L)(N3)](1) (2 was ineffective as catalyst for catecholase reaction) was 
evaluated in methanol by monitoring the increase in absorbance at 400 nm 
as a function of time over the first 5 min corresponding to the formation of 
the quinone product DTBQ (3,5-di-tert-butyl-obenzoquinone). In a typical 
experiment, 2000 μl of a solution of 1 in methanol ([C]o= 6 × 10−4 M) was 
added to a 1-cm-path-length cell containing 3 cm3 of methanol at 25°C. The 
reaction was initiated by the addition of 100 μl of catechol solution ([3, 5-
DTBC]o= 2.0 × 10−3 to 6.0 ×10−2 M). A kinetic treatment on the basis of the 
Michaelis-Menten approach was applied and the various kinetic 
parameters Vmax, KM and kcat were evaluated from Lineweaver-Burk double-
reciprocal plots.78 The observed rate versus [substrate] plot in methanol 
solution as well as Lineweaver–Burk plot are given in Figure 8. The kinetic 
parameters are listed in Table 4. The turnover number (kcat) at 898 h–1  is 
reasonably good. 
 
 
   
 
Complex λmax(nm) λmax(nm) 
Δλ(nm) %Ha bKb(M–1) bKSV (M–1) cKapp  (M–1) 
 Free Bound    
  
1 270 266 4 57.2 5.39 × 108 1.67 × 105 1.07 × 107 
2 270 267 3 17.4 1.08 × 105 2.12 × 105 2.46 × 106 
540 560 580 600 620 640 660 680
0
15000
30000
45000
60000
75000
90000
A
b
s
o
rb
a
n
c
e
Wavelength(nm)
0.0 1.0x10
-6
2.0x10
-6
3.0x10
-6
1.0
1.1
1.2
1.3
1.4
1.5
1.6
I0
/I
[Metal]
Equation y = a + b*
Adj. R-Squar 0.98978
Value Standard Erro
B Intercept 1.00251 0.00756
B Slope 167373.2575 4544.64389
540 560 580 600 620 640 660 680
0
15000
30000
45000
60000
75000
A
b
s
o
rb
a
n
c
e
Wavelength(nm)
0.0 1.0x10
-6
2.0x10
-6
3.0x10
-6
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
I0
/I
[Metal]
Equation y = a + b*x
Adj. R-Square 0.99017
Value Standard Error
B Intercept 1.06135 0.01112
B Slope 211764.25112 5851.01323
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
 
 
                            (a)                                                                                       (b)           
 
 
 
                                            
                                                       
     
 
 
 
 
 
                                                           (c)  
Figure 8 (a) The changes of UV–Vis spectral behavior at regular interval of time for 
complex 1 in methanol medium upon addition of 3,5-DTBC observed after each 5 min 
interval. (b) Plot of rate vs. substrate concentration for complex 1. (c) Linweaver-Burk 
plot of complex 1. 
 
Table 4: Kinetics parameters for the oxidation of 3,5-DTBC catalyzed by Cu (II) 
complex (1). 
 
 
 
 
 
 
 
 
 
3.8.2 Mechanistic aspects towards catalytic oxidation of 3,5-di-tert-
butylcatechol (DTBC) by Complex 1 
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Scheme II: Proposed mechanism of catechol oxidation catalysed by [Cu(L1)(N3)](1). 
 
A plausible mechanism for the catalysis is given in scheme II. It is suggested 
that DTBCH2 displaced the N3– from the coordination sphere and 
coordinates as DTBC2– in a bidentate fashion. One electron transfer from 
DTBC2– converts it to a semiquinone complex having a CuI core. The CuI 
complex rapidly reacts with aerial O2 to give a CuII-superoxo complex, 
containing the semiquinone ligand.  Elctron transfer from the 
semiquionone to superoxide results in dissociation of the quinone and 
conversion of superoxide to hydroperoxide. This is followed by elimination 
of H2O2 and the catalyst is regenerated.21,26,79,80 The detection of H2O2 from 
the reaction mixture provides evidence in favour of the proposed 
mechanism. ESI-MS spectrum (positive ion mode) of a 1:100 mixture of 1 
and 3,5-DTBCH2, recorded after 20 min of mixing of the reactants in 
methanol, shows that apart from the parent complex peak at 300.08, a 
peak with a m/z value of 543.25 which is consistent with the formula of 
[{Cu(L1)(3,5-DTBC2–)}+Na]+(Figure S10 in SI), which thus adds further 
evidence in favour of the proposed mechanism. 
It may be noted that according to the mechanism proposed in scheme II, 
the Cu(II) complex must have a square planar geometry with a labile ligand 
in the square plane, for it to be catalytically active. This may be the reason 
why complex 2, having a chain like structure with 4+1 coordination of the 
Cu(II) center is inactive as a catalyst. Comparing the catalytic efficiency of 
complex 1 with a very similar complex [Cu(L)Cl] (L = −O,N,N-donor Schiff 
base formed by condensation of pyridoxal and 2-aminomethyl pyridine),26 
one observes that [Cu(L)Cl] is ~103 times more catalytically efficient than 
complex 1. The much lower Cu(II)/Cu(I) potential (−0.28 V) of [Cu(L)Cl] 
compared to 1 (−0.55 V), as well as the relatively weaker Cu-Cl bond in the 
former complex compared to much stronger Cu-N3 bond in 1 (dCu-N(Azide) 
=  1.959 (2)Å in 1, d(Cu-Cl) =  2.288(1) Å in [Cu(L)Cl] ]  may account for this 
large difference in their catalytic efficiencies.   
3.9 DFT calculation results 
 
DFT calculations were performed on the complexes and the frontier 
orbitals of 1 are depicted in Figure 9 and while those of 2 are shown in 
Figure S11 in Supplementary material. For complex 1 the SOMO (α-HOMO) 
has only 3.17% contribution from Cu while for complex 2 (monomer) the 
SOMO has only 0.74% Cu contribution. The β-LUMO for complexes 1 and 2 
has 48.37% and 53.38% contribution respectively from Cu.  However, the 
unpaired spin density is predominantly centred on the Cu-atom with the 
contribution of the Cu atom being 48.37% and 51.51% for complexes 1 and 
2 respectively (Figure 10).    
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Figure 9 FMOs of complex 1 in gas phase with ISO value cut off 0.04. 
 
 
 
 
 
 
 
 
Figure 10 Excess spin density (Alfa) on complexes 1 (left) and 2(right) with ISO value 
cut off 0.04. 
 
4. Conclusion. 
Cu(II) complexes bearing a pyridoxal appended tridentate Schiff base ligand 
and azide or thiocyanate coligand are reported in this communication. It is 
shown that the solid state structures are different in the two complexes, 
with azide coordinated complex containing monomeric square planar 
Cu(II), whereas the thiocyanato complex has square pyramidal Cu(II) 
environment and it exists as a one dimensional chain in the solid state. The 
two compounds show different reactivity as catalyst for aerial oxidation of 
catechol (catecholase activity), with complex 1 showing good catalytic 
efficiency while complex 2 is ineffective as catalyst. The differences in the 
structures of these two complexes as well as the instability of the Cu(I) 
species in 2 compared to 1, as reflected in their electrochemical studies 
may be the reason for this difference in catalytic activity. Complex 1 shows 
much stronger DNA-binding ability than complex 2. 
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